+scDRS may be underpowered for certain GWAS/scRNA-seq data sets. In these cases, the ensuing scDRS group analyses may still have sufficient power, because scDRS group analyses aggregate results of individual cells and hence usually have higher power than the scDRS individual cell-level analyses. To assess if scDRS has sufficient power, we suggest performing [`scdrs perform-downstream --group-analysis`](https://martinjzhang.github.io/scDRS/reference_cli.html#perform-downstream) to assess significance at an aggregated level. In addition, it is helpful to visually inspect the scDRS normalized disease score on the UMAP plot. If some parts of the UMAP plot are enriched with clearly higher scDRS disease scores, then scDRS should have detected interesting biological signals in your data.
0 commit comments